Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression

The Level of Isoprostanes as a Non-invasive Marker for in vivo Lipid Peroxidation in Secondary Progressive Multiple Sclerosis

(2011) Elżbieta Miller et al.   NEUROCHEMICAL RESEARCH

Serum elements and oxidative status in clinically isolated syndromes: Imbalance and predictivity

(2011) G. Ristori et al.   NEUROLOGY

B cell expression of the inhibitory Fcγ receptor is unchanged in early MS

(2010) Manuel Comabella et al.   JOURNAL OF NEUROIMMUNOLOGY

Inability of Plasma and Urine F2A-Isoprostane Levels to Differentiate Mild Cognitive Impairment from Alzheimer’s Disease

(2010) Elliott J. Mufson et al.   Neurodegenerative Diseases

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)

(2010) Johannes Brettschneider et al.   PLoS One

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

CSF proteome analysis in clinically isolated syndrome (CIS): Candidate markers for conversion to definite multiple sclerosis

(2009) H. Tumani et al.   NEUROSCIENCE LETTERS